About Us

REFINING THE FERTILITY JOURNEY.

Inti Labs was founded by IVF industry leaders Dr. Barry Behr and biotech start-up veteran Dr. Eric Pok Yang, each representing different aspects of the IVF process. Embryologist Dr. Behr aimed to improve egg evaluation, while Dr. Yang focused on using developing non-invasive diagnostics to increase implantation success rates. Together with the Inti Labs team, they endeavor to reduce the burden on patients through less invasive, more accurate testing solutions.

About Us

REFINING THE FERTILITY JOURNEY.   ​

Inti Labs was founded by IVF industry leaders Dr. Barry Behr and biotech start-up veteran Dr. Eric Pok Yang, each representing different aspects of the IVF process. Embryologist Dr. Behr aimed to improve egg evaluation, while Dr. Yang focused on using developing non-invasive diagnostics to increase implantation success rates. Together with the Inti Labs team, they endeavor to reduce the burden on patients through less invasive, more accurate testing solutions.

OUR MISSION

Inti Labs is dedicated to providing our clinical partners with tools that that consider the unique needs of each individual patient to enable more successful IVF outcomes. Further, we strive to empower patients and their families in making informed decisions at each stage of their fertility journey.

OUR VISION

Refining and streamlining the IVF process to reliably delivery a healthy baby using just a single egg, embryo, and implantation.

OUR TEAM

Dr Eric Pok

Dr. Eric Pok Yang, CEO

Dr. Eric Pok Yang is a distinguished figure in the field of molecular biology and genetics, with over two decades of dedicated research focused on unraveling the complexities of cellular mechanisms. With a notable focus on microRNA (miRNA), Dr. Yang’s contributions have been instrumental in shedding light on critical aspects of gene regulation, DNA repair, and cellular signaling, paving the way for novel therapeutic interventions and, more recently, endometrial receptivity. Today Dr. Yang leads the team at Inti Labs in its pursuit of developing solutions aimed at improving clinical outcomes in IVF.

Dr Barry Behr

Dr. Barry Behr, CTO

Dr. Barry Behr has been a pioneering figure in oocyte research for over two decades, and his work has contributed prominently to advancing our understanding of oocyte biology and improving clinical outcomes in assisted reproductive technology. During his time as a distinguished faculty member at Stanford, he spearheaded several innovative research initiatives, including novel techniques for oocyte cryopreservation, exploration of oocyte maturation processes, and advanced embryo culture techniques. With Inti Labs, Dr. Behr continues to inspire breakthroughs that hold promise for individuals and couples striving to build their families.

Tiffany Wang

Director of Global Business Development

An Hsu, Ph.D.

Director of R&D

Wei-Ming Chen, Ph.D.

Director of Applied Data Science

Mackenzie Emond, MBA

Director of Engagement

Jesse Prent, MBA

Director of Brand Marketing

Lady using a phone

CONTACT US

Have questions or want to learn more about our products and services? Don’t hesitate to reach out to us. We’re here to support patients and professionals alike at every stage of the fertility journey.